ORCID as entered in ROS

Select Publications
2025, 'Mutations of the CEACAM5 Gene PELPK Motif in Patients With Appendiceal or Colorectal Adenocarcinoma', In Vivo, 39, pp. 96 - 101, http://dx.doi.org/10.21873/invivo.13806
,2024, 'Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy: Results of Phase I of the PRECINCT Study in 707 Patients', Annals of Surgical Oncology, 31, pp. 8560 - 8571, http://dx.doi.org/10.1245/s10434-024-16035-9
,2024, 'Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery', World Journal of Surgical Oncology, 22, http://dx.doi.org/10.1186/s12957-024-03392-8
,2024, 'Impact of Previous Abdominal Surgery and Timing of Peritoneal Metastases on Accuracy of Imaging in Predicting the Surgical PCI: A Report From the PRECINCT Study', Journal of Surgical Oncology, 130, pp. 1178 - 1189, http://dx.doi.org/10.1002/jso.27868
,2024, 'The Significance of the Morphological Appearance of Peritoneal Lesions on Imaging in Patients With Peritoneal Malignancies—A Report From Phase 1 of the PRECINCT Study', Journal of Surgical Oncology, 130, pp. 1235 - 1248, http://dx.doi.org/10.1002/jso.27869
,2024, 'The CEA/PCI ratio is a superior prognosticator than mCOREP for colorectal cancer patients with peritoneal carcinomatosis', Surgery Open Science, 19, pp. 28 - 31, http://dx.doi.org/10.1016/j.sopen.2024.03.014
,2024, 'ASO Visual Abstract: Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy—Results of Phase 1 of the PRECINCT Study in 707 Patients', Annals of Surgical Oncology, 31, pp. 8609 - 8610, http://dx.doi.org/10.1245/s10434-024-16200-0
,2023, 'The 'Starburst' Sign: A Novel Description of PET Images in Carcinoma of Unknown Primary', Anticancer Research, 43, pp. 4237 - 4239, http://dx.doi.org/10.21873/anticanres.16616
,2023, 'Outcomes for Colorectal Cancer Cases With Peritoneal Metastases Treated With Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A Comparative Analysis of Survival Between Peritoneal Carcinomatosis Scores - PCI in a Single Centre', Anticancer Research, 43, pp. 3529 - 3538, http://dx.doi.org/10.21873/anticanres.16530
,2023, 'Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis', European Journal of Surgical Oncology, 49, pp. 1489 - 1494, http://dx.doi.org/10.1016/j.ejso.2023.03.214
,2023, 'Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A single centre experience', Pleura and Peritoneum, 8, pp. 83 - 90, http://dx.doi.org/10.1515/pp-2022-0202
,2023, 'Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal', Annals of Surgery, 277, pp. E1063 - E1071, http://dx.doi.org/10.1097/SLA.0000000000005663
,2023, 'Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: A propensity score matched study', Pleura and Peritoneum, 8, pp. 27 - 35, http://dx.doi.org/10.1515/pp-2022-0205
,2023, 'Increased Incidence of Liver Metastases in Colorectal Versus Appendiceal Adenocarcinoma Peritonectomy Patients Despite Equivocal Survival', Anticancer Research, 43, pp. 4657 - 4662, http://dx.doi.org/10.21873/anticanres.16661
,2022, 'Second-look Surgery for Appendiceal High Grade and Colorectal Cancers following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)', In Vivo, 36, pp. 2350 - 2356, http://dx.doi.org/10.21873/invivo.12966
,2022, 'Cytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian Centre', Anticancer Research, 42, pp. 2939 - 2944, http://dx.doi.org/10.21873/anticanres.15776
,2022, 'Case series on high grade appendiceal cancer with peritoneal and liver carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)', International Journal of Surgery Case Reports, 94, http://dx.doi.org/10.1016/j.ijscr.2022.107027
,2022, 'Cost-effectiveness of Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis', In Vivo, 36, pp. 1527 - 1533, http://dx.doi.org/10.21873/invivo.12863
,2022, 'Impact pronostic de la proportion de cellules en bague-à-chaton chez les patients atteints de cancers colorectaux avec métastases péritonéales', Journal de Chirurgie Viscérale, 159, pp. S73 - S73, http://dx.doi.org/10.1016/j.jchirv.2022.07.018
,2021, 'The 5 Year Outcomes of Early Postoperative Intra-Peritoneal Chemotherapy (EPIC) in High-Grade Appendiceal Cancer – Does regimen length and cancer subtype make a difference?', Surgical Research, 3, http://dx.doi.org/10.33425/2689-1093.1038
,2021, 'Risk factors and clinical outcomes in patients undergoing cytoreductive surgery with concomitant ureteric reimplantation', Pleura and Peritoneum, 6, pp. 155 - 160, http://dx.doi.org/10.1515/pp-2021-0130
,2021, 'Peritoneal spread of low-grade appendiceal tumours - 2 days of early postoperative intra-peritoneal chemotherapy are enough', Anticancer Research, 41, pp. 5569 - 5575, http://dx.doi.org/10.21873/anticanres.15370
,2021, 'Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: Study protocol of a prospective, multicentre, observational study', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2020-046819
,2017, 'Improved Clinical Documentation for Improved Communication', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 186 - 187, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500307&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2023, 'Survival outcome of neoadjuvant chemotherapy in cytoreductive surgery and HIPEC for colorectal cancer with peritoneal metastases', presented at PSOGI Congress on Peritoneal Surface Malignancy, 04 October 2023
,2022, 'Prognostic impact of signet ring cell proportion in colorectal cancer patients with peritoneal metastases', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, Vol. 33, pp. S695 - S695, presented at Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 09 September 2022 - 13 September 2022, http://dx.doi.org/10.1016/j.annonc.2022.07.485
,2019, 'Do we have a black cat in a dark room? Looking for patient data in cancer research', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 104 - 105, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2024, The Cea/Pci Ratio is a Superior Prognosticator than Mcorep for Colorectal Cancer Patients with Peritoneal Carcinomatosis, http://dx.doi.org/10.2139/ssrn.4711918
,2021, Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumors treated by cytoreductive surgery: Study protocol of a prospective, multi-center, observational study, http://dx.doi.org/10.1101/2021.04.01.21254760
,